In separate experiments, FITC-folate, FITC-DUPA, and FITC-AZA BsAb treatment with FITC CAR-T cells reduced the tumor volume of in vivo MDA-MB-231 cells overexpressing FRα, PSMA, and CA IX, respectively [74]. Here, CA9 is linked to neoplasm.